Seeking Alpha

Rigel Pharmaceuticals (RIGL +4.5%) is up on the day after JP Morgan initiates coverage with an...

Rigel Pharmaceuticals (RIGL +4.5%) is up on the day after JP Morgan initiates coverage with an overweight. The firm says Rigel's rheumatoid arthritis Fostamatinib shows a lot of promise and the stock will likely gaing in anticipation of positive results.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector